UBS Lux Equity Fund Biotech USD vs Barings Hong Kong China A

UBS Lux Equity Fund Biotech USD vs Barings Hong Kong China A

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. Barings Hong Kong China A

  • Security

    Barings Hong Kong China A USD Inc

  • Fee

    1.25%

  • ISIN

    IE0000829238

  • Holdings

    18

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.9) and Moderna (9.21). In comparison with Barings Hong Kong China A, we have 19 holdings where Tencent is the largest holding (9.55), followed by Alibaba (8.99) and China Construction Bank (5.24).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Barings Hong Kong China A.

UBS Lux Equity Fund Biotech USD Barings Hong Kong China A
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Tencent
China
9.55 %
2. Vertex Pharmaceuticals Inc
9.9 %
2. Alibaba Group Holding Ltd ADR
China
8.99 %
3. Moderna Inc
9.21 %
3. China Construction Bank Corp Class H
China
5.24 %
4. Alnylam Pharmaceuticals Inc
6.54 %
4. Meituan Class B
China
4.96 %
5. AbbVie Inc
USA
5.52 %
5. JD.com Inc
China
4.54 %
6. Gilead Sciences Inc
USA
4.66 %
6. Xiaomi Corp Class B
China
4.3 %
7. Amgen Inc
4.32 %
7. Pinduoduo Inc
China
4.17 %
8. BioNTech SE
4.13 %
8. Ping An Insurance Co
China
3.47 %
9. Karuna Therapeutics Inc
3.75 %
9. NetEase ADR
China
3.15 %
10. Royalty Pharma Plc
3.28 %
10. China Merchants Bank Class H
China
2.65 %
- 11. Trip.com Group Ltd
Singapore
2.21 %
- 12. Agricultural Bank of China Ltd Class H
China
2.16 %
- 13. China Pacific Insurance Co Ltd Class H
China
2.1 %
- 14. BYD Co Ltd Class H
China
2.08 %
- 15. Li Auto Inc
China
1.55 %
- 16. BeOne Medicines Ltd
China
1.44 %
- 17. PetroChina Co Ltd Class H
China
1.32 %
- 18. China Shenhua Energy Co Ltd Class H
China
1.3 %

The list of fund holdings was last updated on April 17, 2025.